Tamarly Intelligence
Private raises · SEC Form D

BIOVENTRIX, INC.: $7 million Raised, SEC Form D Filings

Company · Biotechnology · MA · SEC CIK 1283259

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
8 Oct 2026New notice$3 million$1 millionBiotechnologyForm D
9 Sept 2026Amendment$10 million$3 millionOtherForm D
1 Sept 2026Amendment$10 million$3 millionOtherForm D
24 Apr 2026New notice$6 million$705,000OtherForm D
4 Nov 2025Amendment$12 million$7 millionOtherForm D

Questions and answers

How much has BIOVENTRIX, INC. raised?
BIOVENTRIX, INC. reported $7 million sold in its largest Form D notice on file; its latest notice was filed on 8 October 2026. Form D amounts are what the issuer reported to the SEC.
What is BIOVENTRIX, INC.?
BIOVENTRIX, INC. is a company in biotechnology, based in Mansfield, Massachusetts, according to its SEC Form D filings.
How many Form D notices has BIOVENTRIX, INC. filed?
5 notices between 4 November 2025 and 8 October 2026 in Tamarly's record, which starts on 1 October 2025.
Get an alert when BIOVENTRIX, INC. files again, and see every Form D raise as it arrives; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "BIOVENTRIX, INC.: SEC Form D filings", https://app.tamarly.ai/raisers/1283259, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.